Paving the Path to Prevention: Managing Early Treatments for T1D Progression
Javier Morales, MD, FACP, FACE; Shira Eytan, MD, FACE; Bethany Kinsey, NP; Quentin Van Meter, MD, and David Robertson, MD, discuss the progression and management of Type 1 diabetes, from early screening protocols through disease stages and intervention timing, emphasizing the critical importance of vigilant monitoring and prompt treatment to prevent severe complications.
EP. 1: Living with Type 1 Diabetes
Panelists discuss the burden of living with type 1 diabetes, including high levels of stress and anxiety and talk about how they help patients manage the daily requirements.
EP. 2: Screening Guidelines for Type 1 Diabetes
Panelists discuss early testing with autoantibody screening for type 1 diabetes in at-risk individuals, particularly those with family history or genetic predisposition, to avoid DKA at diagnosis and allow time for patient and family preparation.
EP. 3: Stages and Symptoms of Type 1 Diabetes
Panelists discuss how type 1 diabetes progresses through distinct stages, beginning with asymptomatic autoantibody presence, followed by dysglycemia, and ultimately manifesting with classic symptoms like excessive thirst, frequent urination, and unexplained weight loss.
EP. 4: Impact of Delayed Intervention in Stage 2 Type 1 Diabetes
Panelists discuss how delayed intervention in stage II type 1 diabetes can accelerate β cell destruction, leading to more severe clinical onset, increased risk of serious complications like diabetic ketoacidosis, and poorer long-term outcomes.
